Please login to the form below

Not currently logged in
Email:
Password:

The Research Partnership appoints Vicky McLellan to senior UK role

Healthcare market research and consultancy also promotes Pei Li Teh and Paul Reed

The Research Partnership has appointed Vicky McLellan to its UK quantitative team as an associate director.

Vicky has over 12 years of experience in healthcare market research and has a particular expertise in quantitative research techniques.

UK operations were also boosted by new research executives Anna Spivack, Katie Watts, Anna March Garcia and Jekamohan Vicneswararajah (known as Mohan), and marketing executive Harrison Gaiger.

Meanwhile in the healthcare market research and consultancy firm's Singapore Office, Pei Li Teh and Paul Reed have both been promoted to associate director.

Co-owner Mary Assimakopoulos said: “We are delighted to welcome these talented individuals to our growing team and we congratulate Pei-Li and Paul on their well-deservedpromotions. In this, our 15th anniversary, we are now a company of over 85 global healthcare-specialist market researchers and we have a goal to reach 100 employees with further recruitment in the latter part of 2012."

Headquartered in London, The Research Partnership has offices in Philadelphia and Singapore.

8th August 2012

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Chandler Chicco Companies US

Chandler Chicco Companies (CCC) is a global health communications group that delivers unmatched perspective and creative know-how. Today, healthcare is...

Latest intelligence

Junior Doctor contracts – PR winners and losers
GCI Health's Caroline Howley on who's winning the PR battle around the junior doctors' strike....
21_Faster_results.png
How to get faster results with digital communication
Everyone is under pressure to deliver results fast, so how can you speed up the positive effects of your e-detailing and multichannel communication? One proven answer is to get the...
Business as usual
MHRA explains that its emphasis will remain firmly on vetting when it comes to pharma advertising...

Infographics